𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Chronic treatment with CB1 or CB2 cannabinoid receptors agonists reduces cognitive impairment in a transgenic model of Alzheimer's disease

✍ Scribed by Aso, Ester; Juvés, Salvador; Maldonado, Rafael; Ferrer, Isidre

Book ID
123561372
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
40 KB
Volume
6
Category
Article
ISSN
1552-5260

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The decrease of dopamine D2/D3 receptor
The decrease of dopamine D2/D3 receptor densities in the putamen and nucleus caudatus goes parallel with maintained levels of CB1 cannabinoid receptors in Parkinson's disease: A preliminary autoradiographic study with the selective dopamine D2/D3 antagonist [3H]raclopride and the novel CB1 inverse agonist [125I]SD7015
✍ Szabolcs Farkas; Katalin Nagy; Zhisheng Jia; Tibor Harkany; Miklós Palkovits; Se 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 745 KB